期刊
LANCET
卷 387, 期 10016, 页码 386-394出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(14)61798-0
关键词
-
资金
- Sage Products
- DJ Orthopaedics
- Janssen
- Joint Active Systems
- Medtronic
- Stryker
- TissueGene
- Microport
- National Institutes of Health (NIAMS)
- National Institutes of Health (NICHD)
- Tissue Gene
- Ongoing Care Solutions
- DJO Global
- Orthosensor
- Siemens AG
Periprosthetic joint infections are a devastating complication after arthroplasty and are associated with substantial patient morbidity. More than 25% of revisions are attributed to these infections, which are expected to increase. The increased prevalence of obesity, diabetes, and other comorbidities are some of the reasons for this increase. Recognition of the challenge of surgical site infections in general, and periprosthetic joint infections particularly, has prompted implementation of enhanced prevention measures preoperatively (glycaemic control, skin decontamination, decolonisation, etc), intraoperatively (ultraclean operative environment, blood conservation, etc), and postoperatively (refined anticoagulation, improved wound dressings, etc). Additionally, indications for surgical management have been refined. In this Review, we assess risk factors, preventive measures, diagnoses, clinical features, and treatment options for prosthetic joint infection. An international consensus meeting about such infections identified the best practices and further research needs. Orthopaedics could benefit from enhanced preventive, diagnostic, and treatment methods.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据